1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Digital Dose Inhalers Market 

4. Market Overview

    4.1. Introduction

        4.1.1. Product Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Digital Dose Inhalers Market Analysis and Forecast, 2017–2027

        4.4.1. Global Digital Dose Inhalers Market Revenue Projections (US$ Mn)

5. Market Outlook

    5.1. Technological Advancements

    5.2. Key Industry Events (Mergers, Acquisitions, Product Launch, etc.)

    5.3. Epidemiology of Respiratory Diseases, such as Asthma, COPD (Chronic Obstructive Pulmonary Disease),etc.

6. Global Digital Dose Inhalers Market Analysis and Forecast, by Product 

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Global Digital Dose Inhalers Market Value Forecast, by Product, 2017–2027

        6.3.1. Metered Dose Inhalers  

        6.3.2. Dry Powder Inhalers 

    6.4. Global Digital Dose Inhalers Market Attractiveness, by Product 

7. Global Digital Dose Inhalers Market Analysis and Forecast, by Application 

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Global Digital Dose Inhalers Market Value Forecast, by Application, 2017–2027

        7.3.1. Asthma  

        7.3.2. COPD (Chronic Obstructive Pulmonary Disease)  

        7.3.3. Others

    7.4. Global Digital Dose Inhalers Market Attractiveness, by Application 

8. Global Digital Dose Inhalers Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Global Digital Dose Inhalers Market Value Forecast, by Region

        8.2.1. North America 

        8.2.2. Europe 

        8.2.3. Asia Pacific 

        8.2.4. Latin America 

        8.2.5. Middle East & Africa 

    8.3. Global Digital Dose Inhalers Market Attractiveness, by Region

9. North America Digital Dose Inhalers Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. North America Digital Dose Inhalers Market Value Forecast, by Product, 2017–2027

        9.2.1. Metered Dose Inhalers  

        9.2.2. Dry Powder Inhalers 

    9.3. North America Digital Dose Inhalers Market Value Forecast, by Application, 2017–2027

        9.3.1. Asthma  

        9.3.2. COPD (Chronic Obstructive Pulmonary Disease)  

        9.3.3. Others

    9.4. North America Digital Dose Inhalers Market Value Forecast, by Country/Sub-region, 2017–2027

        9.4.1. U.S.

        9.4.2. Canada

    9.5. North America Digital Dose Inhalers Market Attractiveness Analysis 

        9.5.1. By Product 

        9.5.2. By Application 

        9.5.3. By Country/Sub-region

10. Europe Digital Dose Inhalers Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Europe Digital Dose Inhalers Market Value Forecast, by Product, 2017–2027

        10.2.1. Metered Dose Inhalers  

        10.2.2. Dry Powder Inhalers 

    10.3. Europe Digital Dose Inhalers Market Value Forecast, by Application, 2017–2027

        10.3.1. Asthma  

        10.3.2. COPD (Chronic Obstructive Pulmonary Disease)  

        10.3.3. Others

    10.4. Europe Digital Dose Inhalers Market Value Forecast, by Country/Sub-region, 2017–2027

        10.4.1. Germany

        10.4.2. U.K.

        10.4.3. France

        10.4.4. Spain

        10.4.5. Italy

        10.4.6. Rest of Europe

    10.5. Europe Digital Dose Inhalers Market Attractiveness Analysis 

        10.5.1. By Product 

        10.5.2. By Application 

        10.5.3. By Country/Sub-region

11. Asia Pacific Digital Dose Inhalers Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Asia Pacific Digital Dose Inhalers Market Value Forecast, by Product, 2017–2027

        11.2.1. Metered Dose Inhalers  

        11.2.2. Dry Powder Inhalers 

    11.3. Asia Pacific Digital Dose Inhalers Market Value Forecast, by Application, 2017–2027

        11.3.1. Asthma  

        11.3.2. COPD (Chronic Obstructive Pulmonary Disease)  

        11.3.3. Others

    11.4. Asia Pacific Digital Dose Inhalers Market Value Forecast, by Country/Sub-region, 2017–2027

        11.4.1. China

        11.4.2. Japan

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of Asia Pacific

    11.5. Asia Pacific Digital Dose Inhalers Market Attractiveness Analysis 

        11.5.1. By Product 

        11.5.2. By Application 

        11.5.3. By Country/Sub-region

12. Latin America Digital Dose Inhalers Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Latin America Digital Dose Inhalers Market Value Forecast, by Product, 2017–2027

        12.2.1. Metered Dose Inhalers  

        12.2.2. Dry Powder Inhalers 

    12.3. Latin America Digital Dose Inhalers Market Value Forecast, by Application, 2017–2027

        12.3.1. Asthma  

        12.3.2. COPD (Chronic Obstructive Pulmonary Disease)  

        12.3.3. Others

    12.4. Latin America Digital Dose Inhalers Market Value Forecast, by Country/Sub-region, 2017–2027

        12.4.1. Brazil

        12.4.2. Mexico

        12.4.3. Rest of Latin America

    12.5. Latin America Digital Dose Inhalers Market Attractiveness Analysis 

        12.5.1. By Product 

        12.5.2. By Application 

        12.5.3. By Country/Sub-region

13. Middle East & Africa Digital Dose Inhalers Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Middle East & Africa Digital Dose Inhalers Market Value Forecast, by Product, 2017–2027

        13.2.1. Metered Dose Inhalers  

        13.2.2. Dry Powder Inhalers 

    13.3. Middle East & Africa Digital Dose Inhalers Market Value Forecast, by Application, 2017–2027

        13.3.1. Asthma  

        13.3.2. COPD (Chronic Obstructive Pulmonary Disease)  

        13.3.3. Others

    13.4. Middle East & Africa Digital Dose Inhalers Market Value Forecast, by Country/Sub-region, 2017–2027

        13.4.1. GCC Countries

        13.4.2. South Africa

        13.4.3. Israel

        13.4.4. Rest of Middle East & Africa

    13.5. Middle East & Africa Digital Dose Inhalers Market Attractiveness Analysis 

        13.5.1. By Product 

        13.5.2. By Application 

        13.5.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player – Competition Matrix (By Tier and Size of companies)

    14.2. Market Share/Position Analysis By Company (2018)

    14.3. Company Profiles

        14.3.1. Novartis AG 

            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.1.2. Company Financials

            14.3.1.3. Growth Strategies

            14.3.1.4. SWOT Analysis

        14.3.2. AstraZeneca 

            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.2.2. Company Financials

            14.3.2.3. Growth Strategies

            14.3.2.4. SWOT Analysis

        14.3.3. Glenmark

            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.3.2. Company Financials

            14.3.3.3. Growth Strategies

            14.3.3.4. SWOT Analysis 

        14.3.4. GlaxoSmithKline plc. 

            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.4.2. Company Financials

            14.3.4.3. Growth Strategies

            14.3.4.4. SWOT Analysis

        14.3.5. Teva Pharmaceutical Industries Ltd 

            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.5.2. Company Financials

            14.3.5.3. Growth Strategies

            14.3.5.4. SWOT Analysis

        14.3.6. 3M 

            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.6.2. Company Financials

            14.3.6.3. Growth Strategies

            14.3.6.4. SWOT Analysis

        14.3.7. Sensirion AG Switzerland 

            14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.7.2. Company Financials

            14.3.7.3. Growth Strategies

            14.3.7.4. SWOT Analysis

        14.3.8. AptarGroup, Inc. 

            14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.8.2. Company Financials

            14.3.8.3. Growth Strategies

            14.3.8.4. SWOT Analysis

        14.3.9. Cipla Inc.

            14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.9.2. Company Financials

            14.3.9.3. Growth Strategies

            14.3.9.4. SWOT Analysis

        14.3.10. H&T Presspart Manufacturing Ltd 

            14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.10.2. Company Financials

            14.3.10.3. Growth Strategies

            14.3.10.4.  SWOT Analysis

Note: Financial details for companies that do not report this information in public domain might not be captured

List of Tables

Table 01: Epidemiology of Respiratory Diseases, such as Asthma, COPD (Chronic Obstructive  Pulmonary Disease),etc.
Table 02: Epidemiology of Respiratory Diseases, such as Asthma, COPD (Chronic Obstructive Pulmonary Disease),etc.
Table 03: Global Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 04: Global Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 05: Global Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 06: North America Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 07: North America Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 08: North America Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 09: Europe Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 10: Europe Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 11: Europe Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 12: Asia Pacific Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 13: Asia Pacific Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 14: Asia Pacific Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 15: Latin America Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 16: Latin America Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 17: Latin America Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 18: Middle East & Africa Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 19: Middle East & Africa Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 20: Middle East & Africa Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Application, 2017–2027

List of Figures

Figure 01: Global Digital Dose Inhalers Market Size (US$ Mn) and Distribution, by Region, 2018 and 2027
Figure 02: Global Digital Dose Inhalers
Figure 03: Global Digital Dose Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 04: Global Digital Dose Inhalers Market Value Share (%), by Product, 2018 and 2027
Figure 05: Global Digital Dose Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Metered Dose Inhalers, 2017–2027
Figure 06: Global Digital Dose Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Dry Powder Inhalers, 2017–2027
Figure 07: Global Digital Dose Inhalers Market Attractiveness Analysis, by Product, 2019–2027
Figure 08: Global Digital Dose Inhalers Market Value Share, by Application, 2018 and 2027
Figure 09: Global Digital Dose Inhalers Market Attractiveness, by Application, 2019–2027
Figure 10: Global Digital Dose Inhalers Market Value (US$ Mn) and Y-o-Y Growth, by Asthma, 2017–2027
Figure 11: Global Digital Dose Inhalers Market Value (US$ Mn) and Y-o-Y Growth, by COPD (Chronic Obstructive Pulmonary Disease), 2017–2027
Figure 12: Global Digital Dose Inhalers Market Value (US$ Mn) and Y-o-Y Growth, by Others, 2017–2027
Figure 13: Global Digital Dose Inhalers Market Value Share, by Region, 2018 and 2027
Figure 14: Global Digital Dose Inhalers Market Attractiveness, by Region, 2019–2027
Figure 15: North America Digital Dose Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 16: North America Digital Dose Inhalers Market Value Share (%), by Country, 2018 and 2027
Figure 17: North America Digital Dose Inhalers Market Attractiveness, by Country, 2019–2027
Figure 18: North America Digital Dose Inhalers Market Value Share, by Product, 2018 and 2027
Figure 19: North America Digital Dose Inhalers Market Attractiveness, by Product, 2019–2027
Figure 20: North America Digital Dose Inhalers Market Value Share Analysis, by Application, 2018 and 2027
Figure 21: North America Digital Dose Inhalers Market Attractiveness, by Application, 2019–2027
Figure 22: Europe Digital Dose Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%)2017–2027
Figure 23: Europe Digital Dose Inhalers Market Value Share (%), by Country / Sub-region, 2018 and 2027
Figure 24: Europe Digital Dose Inhalers Market Attractiveness, by Country / Sub-region, 2019–2027
Figure 25: Europe Digital Dose Inhalers Market Value Share, by Product, 2018 and 2027
Figure 26: Europe Digital Dose Inhalers Market Attractiveness, by Product, 2019–2027
Figure 27: Europe Digital Dose Inhalers Market Value Share Analysis, by Application, 2018 and 2027
Figure 28: Europe Digital Dose Inhalers Market Attractiveness, by Application, 2019–2027
Figure 29: Asia Pacific Digital Dose Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 30: Asia Pacific Digital Dose Inhalers Market Value Share (%), by Country/Sub-region, 2018 and 2027
Figure 31: Asia Pacific Digital Dose Inhalers Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 32: Asia Pacific Digital Dose Inhalers Market Value Share, by Product, 2018 and 2027
Figure 33: Asia Pacific Digital Dose Inhalers Market Attractiveness, by Product, 2019–2027
Figure 34: Asia Pacific Digital Dose Inhalers Market Value Share Analysis, by Application, 2018 and 2027
Figure 35: Asia Pacific Digital Dose Inhalers Market Attractiveness, by Application, 2019–2027
Figure 36: Latin America Digital Dose Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 37: Latin America Digital Dose Inhalers Market Value Share (%), by Country / Sub-region, 2018 and 2027
Figure 38: Latin America Digital Dose Inhalers Market Attractiveness, by Country / Sub-region, 2019–2027
Figure 39: Latin America Digital Dose Inhalers Market Value Share, by Product, 2018 and 2027
Figure 40: Latin America Digital Dose Inhalers Market Attractiveness, by Product, 2019–2027
Figure 41: Latin America Digital Dose Inhalers Market Value Share Analysis, by Application, 2018 and 2027
Figure 42: Latin America Digital Dose Inhalers Market Attractiveness, by Application, 2019–2027
Figure 43: Middle East & Africa Digital Dose Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 44: Middle East & Africa Digital Dose Inhalers Market Value Share (%), by Country/Sub-region, 2018 and 2027
Figure 45: Middle East & Africa Digital Dose Inhalers Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 46: Middle East & Africa Digital Dose Inhalers Market Value Share, by Product, 2018 and 2027
Figure 47: Middle East & Africa Digital Dose Inhalers Market Attractiveness, by Product, 2019–2027
Figure 48: Middle East & Africa Digital Dose Inhalers Market Value Share Analysis, by Application, 2018 and 2027
Figure 49: Middle East & Africa Digital Dose Inhalers Market Attractiveness, by Application, 2019–2027
Figure 50: Novartis AG Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2018
Figure 51: Novartis AG R&D Intensity and Sales & Marketing Intensity - Company Level, 2017–2018
Figure 52: Novartis AG Breakdown of Net Sales (%), by Region, 2018
Figure 53: Novartis AG Breakdown of Net Sales (%), by Business Segment, 2018
Figure 54: AstraZeneca Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2018
Figure 55: AstraZeneca R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2018
Figure 56: AstraZeneca Breakdown of Net Sales (%), by Region, 2018
Figure 57: AstraZeneca Respiratory Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2018
Figure 58: Glenmark (US$ Mn) Revenue, 2017–2018
Figure 59: Distribution of Glenmark Revenue (%), by Region, 2018
Figure 60: GlaxoSmithKline plc. Revenue (US$ Mn), 2017–2018
Figure 61: GlaxoSmithKline plc. R&D Expenses (US$ Mn), 2017–2018
Figure 62: GlaxoSmithKline plc. Breakdown of Net Sales (%), by Region, 2018
Figure 63: GlaxoSmithKline plc. Breakdown of Net Sales (%), by Business Segment, 2018
Figure 64: Teva Pharmaceutical Industries Ltd Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2018
Figure 65: Teva Pharmaceutical Industries Ltd R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2018
Figure 66: Teva Pharmaceutical Industries Ltd Breakdown of Net Sales (%), by Region, 2018
Figure 67: 3M, Revenue (US$ Mn) & Y-o-Y Growth (%), 2016–2018
Figure 68: 3M, R&D Expenses (US$ Mn) & Y-o-Y Growth (%), 2016-2018
Figure 69: 3M, Breakdown of Net Sales (%), by Region, 2018
Figure 70: 3M Breakdown of Net Sales (%), by Business Segment, 2018
Figure 71: Sensirion AG Switzerland, Revenue (US$ Mn) & Y-o-Y Growth (%), 2016–2018
Figure 72: Sensirion AG Switzerland, R&D Expenses (US$ Mn), 2017-2018
Figure 73: Sensirion AG Switzerland, Breakdown of Net Sales (%), by Region, 2018
Figure 74: Sensirion AG Switzerland, Breakdown of Net Sales (%), by Business Segment, 2018
Figure 75: AptarGroup, Inc., Revenue (US$ Mn) & Y-o-Y Growth (%), 2016–2018
Figure 76: AptarGroup, Inc., R&D Expenses (US$ Mn), 2016-2018
Figure 77: AptarGroup, Inc., Breakdown of Net Sales (%), by Region, 2018
Figure 78: AptarGroup, Inc., Breakdown of Net Sales (US$ Mn), by Business Segment, 2018
Figure 79: Cipla Inc., Revenue (US$ Mn), 2017–2018
Figure 80: Cipla Inc., Breakdown of Net Sales (%), by Region, 2018
Figure 81: Cipla Inc., Breakdown of Net Sales (%), by Business Segment, 2018